What are the risks of serious infections and malignancies for patients treated with anti-tumor necrosis factor antibodies?

被引：7

作者：

Corona, Rosamaria

Bigby, Michael

机构：

[1] Ist Dermopat Immacolata, I-00167 Rome, Italy

[2] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA

[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

ARCHIVES OF DERMATOLOGY | 2007年 / 143卷 / 03期

关键词：

D O I：

10.1001/archderm.143.3.405

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 [皮肤病与性病学];

摘要：

Commentary on: Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

引用

页码：405 / 406

页数：2

共 3 条

[1]

[Anonymous], 1996, Evidence-based medicine: How to practice and teach EBM

[2]

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists [J].

Askling, J ;

Fored, CM ;

Brandt, L ;

Baecklund, E ;

Bertilsson, L ;

Feltelus, N ;

Cöster, L ;

Geborek, P ;

Jacobsson, LT ;

Lindblad, S ;

Lysholm, J ;

Rantapää-Dahlqvist, S ;

Saxne, T ;

Klareskog, L .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1421-1426

[3]

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data [J].

Sweeting, MJ ;

Sutton, AJ ;

Lambert, PC .

STATISTICS IN MEDICINE, 2004, 23 (09) :1351-1375

← 1 →